Last reviewed · How we verify
Benfotiamine 1050mg, 3 days — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Benfotiamine 1050mg, 3 days (Benfotiamine 1050mg, 3 days) — Ruhr University of Bochum.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Benfotiamine 1050mg, 3 days TARGET | Benfotiamine 1050mg, 3 days | Ruhr University of Bochum | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Benfotiamine 1050mg, 3 days CI watch — RSS
- Benfotiamine 1050mg, 3 days CI watch — Atom
- Benfotiamine 1050mg, 3 days CI watch — JSON
- Benfotiamine 1050mg, 3 days alone — RSS
Cite this brief
Drug Landscape (2026). Benfotiamine 1050mg, 3 days — Competitive Intelligence Brief. https://druglandscape.com/ci/benfotiamine-1050mg-3-days. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab